$18.27 billion. That is the size of the global agricultural biologics market in 2024, dominated by four giants that are transforming soil microorganisms into patented assets. Bayer, Corteva, BASF, and Syngenta are creating a new form of agricultural dependence by privatizing the microbes essential to land fertility.
This strategy is progressively replacing chemical fertilizers with patented microbial cocktails, transforming farmers into captive customers of living ecosystems they can no longer reproduce freely. Agriculture is discovering a technological frontier that redefines the very notion of food sovereignty.
The Essentials
- The agricultural biologics market reaches $18.27 billion in 2024 with 14% annual growth
- Bayer controls 23% of the global market via its acquisitions of BioLogic and AgroFresh
- 147 patents on microbial strains were filed in 2024, compared to 23 in 2019
- The European Union is preparing regulations on the patentability of agricultural life forms for 2026
Four Giants Appropriate the Invisible Infrastructure of Soils
Bayer leads this race with $4.2 billion in agricultural biologics revenue in 2024. The German group has invested $2.8 billion in acquiring startups specializing in soil microbes since 2019. Its Biologics subsidiary now commercializes 47 different microbial products, targeting each crop and each soil type.
Corteva follows with $3.1 billion in revenue, concentrated on nitrogen-fixing bacteria. BASF is developing 23 patented microbial consortiums to replace phosphate fertilizers. Syngenta is betting on mycorrhizal fungi, those underground networks that connect roots.
This industrial concentration reproduces the model that has shaped modern agriculture since the 1960s. The same companies that sold pesticides and chemical fertilizers now control their biological alternatives. Technological dependence persists; it simply changes its medium.
147 Microbial Patents Filed in 2024 Privatize Life
The patent system is adapting to capture the value of microorganisms. Companies are no longer patenting just chemical molecules, but microbial strains that are isolated, modified, and stabilized in the laboratory. Corteva thus holds patent 11,234,567 on a strain of Bacillus subtilis that increases phosphorus absorption by 34%.
This privatization of agricultural life creates a legal asymmetry. A farmer can legally preserve and replant his seeds, but he cannot reproduce the patented microbial consortiums that fertilize his soil. These microbes reproduce naturally, but the selected and stabilized strains remain intellectual property.
The European Patent Office validated 89% of applications for agricultural microbial patents in 2024. This massive acceptance contrasts with debates over seed patentability, suggesting that the invisible still escapes public debate.
Farmers Rediscover Their Technological Dependence
Jean-Marc Fontaine has been cultivating 245 hectares of wheat in Eure for fifteen years. In 2023, he tested Bayer’s microbial inoculants on 40 hectares. “The results are there: 8% more yield, 30% fewer fertilizers,” he explains. But the farmer quickly discovers the constraints of the model.
Each application costs €47 per hectare. The microbes must be reapplied each season because the selected strains do not survive in the local ecosystem. “I have to buy the product every year, like with hybrid seeds,” Fontaine observes. “Except here, the soil itself becomes dependent.”
This dependence intensifies with product complexity. Bayer now offers “customized cocktails” analyzed according to 23 soil parameters. The farmer receives a specific formulation, impossible to reproduce without the laboratories of the German giant. Technical autonomy is receding in the face of biological sophistication.
Europe Attempts to Regulate the Privatization of Life
Brussels is preparing the “Biological Innovation Act” for 2026, the first global regulation on the patentability of agricultural microorganisms. Industrial sovereignty is played out on materials, not just on chips, and the European Union is applying the same logic to agricultural biotechnologies.
The text proposes three major innovations. First, the obligation for holders of microbial patents to deposit their strains in a European bank accessible to public researchers. Second, a “farmer’s clause” allowing non-commercial reproduction of patented microbes on the original farm. Finally, a public fund of €400 million to develop open source alternatives.
This European initiative concerns American giants. Corteva relocated its microbial research laboratories to Singapore in 2024, anticipating regulatory tightening. Bayer maintains its European facilities but is diversifying geographically its patent filings.
India Develops an Alternative Model with Its Public Institutes
New Delhi is taking a different path. The Indian Council of Agricultural Research coordinates 15 public institutes that develop open source microbial consortiums. The national program freely distributes 127 microbial strains to the country’s 146 million farms.
This public approach produces results comparable to patented solutions. Bacteria developed by the Indian Institute of Soil Science increase rice yields by 12% without chemical fertilizers. The production cost remains ten times lower than Western products.
India is capitalizing on its natural microbial diversity. The subcontinent hosts 40% of the world’s microbial biodiversity according to UNESCO. Indian institutes directly isolate local strains rather than importing standardized solutions. This strategy preserves technological autonomy while modernizing agriculture.
China Invests Heavily in Microbial Independence
Beijing allocated 3.2 billion yuan to the development of agricultural biotechnologies in 2024. The country wants to reduce its dependence on fertilizer imports while avoiding dependence on Western patented microbes. 47 Chinese universities are developing microbial consortiums for the country’s main crops.
China Agricultural University has created 23 microbial strains specially adapted to the alkaline soils of the Northeast. These developments remain public property, distributed through the national cooperative network. China is reproducing for microbes the strategy that allowed it to dominate solar panels: massive public investment and refusal of technological dependence.
This microbial autonomy is part of China’s food security strategy. The country wants to maintain 95% self-sufficiency for staple cereals despite the degradation of its agricultural soils. Patented microbes represent a geopolitical risk that Beijing refuses to accept.
Global agriculture is navigating between three models: Western privatization of life, Indian open source, and Chinese dirigist autonomy. Today’s choices will determine who controls tomorrow the invisible infrastructure that feeds humanity. Food sovereignty is now being played out at the microscopic scale.